Skip to Main Content
Table 3.

Prenatal DES exposure in relation to risk of invasive breast cancer

Exposed
Unexposed
Age-adjusted IRR* (95% CI)Multivariable IRR (95% CI)
Person-years of follow-upCasesPerson-years of follow-upCases
Entire cohort 98,591 76 35,046 26 1.40 (0.89-2.22) 1.40 (0.86-2.29) 
Age <40 y 69,243 16 21,988 0.61 (0.27-1.38) 0.57 (0.24-1.34) 
Age ≥40 y 29,348 60 13,058 17 1.91 (1.09-3.33) 2.05 (1.12-3.76) 
Age 40-49 y 26,433 46 10,843 12 1.60 (0.85-3.02) 1.62 (0.83-3.18) 
Age ≥50 y 2,915 14 2,215 3.00 (1.01-8.98) 3.85 (1.06-14.0) 
Exposed
Unexposed
Age-adjusted IRR* (95% CI)Multivariable IRR (95% CI)
Person-years of follow-upCasesPerson-years of follow-upCases
Entire cohort 98,591 76 35,046 26 1.40 (0.89-2.22) 1.40 (0.86-2.29) 
Age <40 y 69,243 16 21,988 0.61 (0.27-1.38) 0.57 (0.24-1.34) 
Age ≥40 y 29,348 60 13,058 17 1.91 (1.09-3.33) 2.05 (1.12-3.76) 
Age 40-49 y 26,433 46 10,843 12 1.60 (0.85-3.02) 1.62 (0.83-3.18) 
Age ≥50 y 2,915 14 2,215 3.00 (1.01-8.98) 3.85 (1.06-14.0) 
*

IRR for breast cancer incidence in exposed women relative to unexposed.

Adjusted for age, years of education, number of births, age at 1st birth, age at menarche, use of female hormone supplements, use of oral contraceptives, family history of breast cancer, birthweight, and cohort.

Close Modal

or Create an Account

Close Modal
Close Modal